ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMC.GB Crism Therapeutics Corp

11.00
0.00 (0.00%)
13 Dec 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Crism Therapeutics Corp AQSE:AMC.GB Aquis Stock Exchange Ordinary Share VGG042401262
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.00 8.00 14.00 11.00 11.00 11.00 0.00 06:59:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amur Minerals Corporation Annual General Meeting Results (6060I)

05/12/2022 10:43am

UK Regulatory


Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart


From Dec 2021 to Dec 2024

Click Here for more Crism Therapeutics Charts.

TIDMAMC

RNS Number : 6060I

Amur Minerals Corporation

05 December 2022

5 December 2022

AMUR MINERALS CORPORATION

(AIM: AMC)

Annual General Meeting Results

The Annual General Meeting ("AGM") of Amur Minerals Corporation ("Amur" or the "Company"), a nickel-copper sulphide mineral exploration development company presently focused on the far east of Russia, was held at 10 a.m. on 5 December 2022 at the office of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London EC4R 3TT, UK. All resolutions were duly passed as follows:

-- Resolution 1; the approval of the Financial Statements and the Report by BDO LLP for the year ended 31 December 2021;

   --    Resolution 2; the re-appointment of the Company's auditor BDO LLP; 
   --    Resolution 3; Mr. Robin Young's re-appointment as a Director of the Company; and 

-- Resolution 4; authorisation to allot up to 200,000,000 shares during the period between now and the next AGM.

-- Resolution 5; the removal of pre-emptive rights in respect of the authorization to allot up to 200,000,000 shares.

The total number of votes received on the resolutions are as follows:

 
 Resolution       Votes         % In       Votes     % Against     Votes         % of        Votes 
                   For &        Favour    Against                   Total      Available    Withheld 
               Discretionary                                                    Voting 
                                                                                Rights* 
-----------  ---------------  --------  ----------                                        ---------- 
     1          24,892,720      100.0        0          0.0      24,892,720      1.8%       167,398 
     2          24,892,720      100.0        0          0.0      24,892,720      1.8%       167,398 
     3          19,138,575      77.0     5,712,316     23.0      24,850,891      1.8%       209,227 
     4          20,511,593      82.5     4,339,298     17.5      24,850,891      1.8%       209,227 
     5          20,511,593      82.5     4,339,298     17.5      24,850,891      1.8%       209,227 
             ---------------  --------  ----------  ----------  -----------  -----------  ---------- 
 

* Available Voting Rights equals 1,392,872,315.

Enquiries:

 
       Company            Nomad and Broker        Public Relations 
  Amur Minerals Corp.    S.P. Angel Corporate         BlytheRay 
                             Finance LLP 
   Robin Young CEO        Richard Morrison           Megan Ray 
                              Adam Cowl              Tim Blythe 
  +1 (925) 408-4621     +44 (0) 20 3470 0470    +44 (0) 20 7138 3203 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGEAEASEDNAFFA

(END) Dow Jones Newswires

December 05, 2022 05:43 ET (10:43 GMT)

1 Year Crism Therapeutics Chart

1 Year Crism Therapeutics Chart

1 Month Crism Therapeutics Chart

1 Month Crism Therapeutics Chart

Your Recent History

Delayed Upgrade Clock